Thanks for posting this article. Everyone here should read

New Post Public Reply Private Reply Replies (3) Message Board
riskreward007 cphillips82 #49878
1,116
Thanks for posting this article. Everyone here should read this. Most of the other recent articles I've read about the current state of our patent system seem to draw similar conclusions.

What is Alice 101?

Alice Corporation owned four patents on electronic methods and computer programs for financial-trading systems. Alice alleged that CLS Bank International began to use similar technology in 2002. Alice accused CLS Bank of infringement of Alice's patents. The issue in the case was whether certain claims about a computer-implemented, electronic escrow service for facilitating financial transactions covered abstract ideas ineligible for patent protection.

In 2014 Alice Corporation's patents were held to be invalid by the Supreme Court of the US (SCOTUS) because the claims were about abstract ideas, and implementing those claims on a computer was not enough to transform that idea into patentable subject matter. It declared each of Alice's patents invalid because the claims concerned abstract ideas. Abstract ideas are not eligible for patent protection under 35 U.S.C. § 101.[9]

https://en.wikipedia.org/wiki/Alice_Corp._v._...ernational

By instituting "Alice 101" SCOTUS unknowingly created a huge pandora's box in the patent system. For all future cases, they left up to the lower courts to determine whether a given patent infringement case was based on "abstract ideas" or not. But SCOTUS didn't realize that the lower courts weren't willing to define "abstract ideas" either (and would just kick the can down the road). Hence the current "mess" in the patent enforcement system was created.

Quote:
Because the Supreme Court seems to have very intentionally said we’re not going to define “abstract idea.” What the Supreme Court has said is, “oh, well, the inferior courts or lower courts or people who aren’t us, will figure it out.” And now we’ve got the Federal Circuit saying, “well, if they don’t have to define it, then we don’t have to define it, we just do a matching game. A matching game is doomed to failure.

https://www.ipwatchdog.com/2019/01/30/ibm-cal...id=105754/


Quote:
Re: The "Alice 101" nightmare:

Simply by filing a patent infringement complaint, over half the time, the patentee not only lost the litigation, but also lost its patent right, and 75% of those losses were not appealed.

Of that lucky 25% that had the resources to request Federal Circuit review, fewer than one-half of them, or 57 of the 122 appeals of district court invalidations, received opinions from the Federal Circuit. The rest received the dreaded “Rule 36 Affirmance,” which provides no guidance to the litigants or to others trying to navigate these dangerous waters.

Even today, the Federal Circuit’s post-Alice decisions tell us that no patent is safe from Section 101. And, if you can believe it, no Federal Circuit decision has defined what “abstract” means, even though courts have invalidated several hundred patents as being “abstract.”

https://www.ipwatchdog.com/2018/09/18/alice-a...id=101447/


My conclusions from these articles:

1) The above quotes show you just what an overall mess this is. The problem is not just our (SFOR's) problem, but there is a much larger system-wide problem with "Alice 101" and patent enforcement. No matter how strong the patent enforcement case is, all the other side has to do is cite "Alice 101" to get off the hook, with the courts not even addressing or understanding the merits of the case (which is what happened to us).

2) By not addressing or being willing to define what is inventiveness or "abstract idea" (see above) both SCOTUS and the Federal Circuit courts are just kicking the can down the road, which makes actual patent infringement resolution nearly impossible in most situations, -a frustrating scenario for almost every company that brings clear cases of patent infringement to the court system.

Why did all this happen?

At some point the Supreme Court (SCOTUS) seemed to be unhappy with the USPTO's (United States Patent and Trademark Office) policies and guidance, so they took on "Alice 101". Alice 101 became a precedent in patent infringement cases, and rather than being a fix, it opened up a huge can of worms, which has become an enormous problem for patent enforcement.

What can be done (in SFOR's case) and in the big picture?

Most articles that I have read say that this larger problem needs to be addressed and fixed (either by SCOTUS or by Congress), hopefully sooner rather than later, -in order to straighten out the mess in the patent system that SCOTUS and "Alice 101" created.

SFOR is caught up in the middle of this much larger patent enforcement system problem. At least we didn't lose our patent eligibility (like many patent infringement litigants).

All we can do is hang in there (with our appeals) until the problem is resolved. This is all the more reason why SFOR should continue its pursuit of an appeal, until this larger problem is resolved (because it's not just our problem, it's everyone's problem). It's possible that delays in our appeal process could actually benefit SFOR, (if SCOTUS or Congress were to step up and resolve this problem in the interim).

Originally I posted that the best option for an SFOR appeal probably was to have our case reviewed by the entire panel of 12 Federal Circuit Court judges. But I have since changed my mind (after reading and studying the above), and have concluded that an appeal to the Federal Circuit court is probably not our best option. Instead I think that SFOR should take its case directly to the Supreme Court (SCOTUS).

Why?

Because SCOTUS is the only court large enough to resolve this systemic problem, and because I doubt that the 12 Federal Circuit Court judges would do anything new (either in resolving SFOR's case or in resolving this larger issue). I think the Federal Circuit Court would just continue to kick the can down the road and wait for someone else (SCOTUS or Congress) to solve the problem.
In other words, if we were to take our case to the Federal Circuit Court again, I think we would lose again for the third time.

But there may be hope. Since there is a bigger awareness of this overall problem, there is the possibility that it may somehow get resolved soon.

All IMO.
RR007

Other relevant articles:
https://www.ipwatchdog.com/2019/01/11/new-cou...id=104975/

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioMarin Strikes Deal for New Fabry Disease Therapy

Updated Category News Views 35

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Continue Reading
SCI Faces Investigation After Earnings Downgrade

Updated Category News Views 33

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Continue Reading
Palmetto Publishing's M&A Guide Aims to Boost Home Services

Updated Category News Views 38

Palmetto's New Release: Mergers & Acquisitions Focus Man, Palmetto Publishing just dropped a bombshell for home services aficionados with their latest M&A guide. Now, if you’re like me, swimming in stocks and always looking for that next big exit play, this one’s tailor-made for you. Mergers and acquisitions might not sound as flashy as the tech darlings or...

Continue Reading
Why Haunted Attractions Keep Us Coming Back for Fear

Updated Category News Views 90

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Continue Reading
David Cornue Brings Story Insights to SXSW 2027

Updated Category News Views 89

Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...

Continue Reading
Solink Secures $100M: NYSE Sees Tech and Sports Moves

Updated Category News Views 101

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 39

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Updated Category News Views 29

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

Continue Reading
OPC Energy Refinances $825M for U.S. Power Plants

Updated Category News Views 40

Strategic Financial Move for OPC Energy Here's the scoop from the powerhouse behind some major U.S. electricity moves: OPC Energy and its subsidiary CPV nailed down a hefty $825 million financing package for the Shore and Maryland power plants. This isn’t just any old financial shuffle. Nope, they've hammered out an all-in-one refinancing deal that's setting the stage...

Continue Reading
wagamama Spruces Up U.S. Market with mamago Launch

Updated Category News Views 80

What's Cooking at wagamama with mamago? Here comes wagamama, striding into the American dining scene with that familiar bold Pan-Asian flair, now offering more than just a seat at their tables. The fresh move to a direct-to-door model dubbed ‘mamago’ ushers in an era where their signature dishes don't just seduce your taste buds at their restaurants. Nope, they are...

Continue Reading

Top 5 Most Recently Viewed Articles

United Community Banks Declares Quarterly Dividend for Investors

Updated Category News Views 81

United Community Banks, Inc. Declares Quarterly Cash Dividend United Community Banks, Inc. (NYSE: UCB) has made an exciting announcement regarding its preferred stock dividends, affirming its dedication to rewarding shareholders. The Board of Directors has approved a quarterly cash dividend set at $429.6875 per share. This translates to $0.4296875 for each depositary...

Continue Reading
Tempest’s Amezalpat Therapy Receives Crucial Approval in China

Updated Category News Views 214

Tempest Therapeutics Advances Amezalpat in Pivotal Trial Tempest Therapeutics, Inc. (Nasdaq: TPST) is thrilled to announce a major step forward in the fight against hepatocellular carcinoma (HCC), having received approval from China’s National Medical Products Administration (NMPA) to initiate a pivotal trial. This trial aims to evaluate the efficacy of amezalpat...

Continue Reading
Exploring the Growth of Hydrophilic Coating Market Trends

Updated Category News Views 150

Overview of the Hydrophilic Coating Market Growth The hydrophilic coating market is on a remarkable trajectory, with projections indicating a growth from USD 16.59 billion in 2023 to USD 27.23 billion by 2032, translating to a compound annual growth rate (CAGR) of 5.66% during this period. This surge is largely driven by advancements in biomedical technology and an...

Continue Reading
Counterweight Market Growth: Key Insights for Investors

Updated Category News Views 142

Counterweight Market Overview and Projected Growth The counterweight market is witnessing accelerated expansion, expected to reach approximately USD 6.1 billion by the year 2031. With a robust growth rate of around 4.9% during the forecast period, this sector is driven by the increasing demand across a wide range of applications. From elevators and forklifts to cranes and...

Continue Reading
VerticalScope Set to Reveal 2024 Financial Outcomes Soon

Updated Category News Views 193

VerticalScope Prepares for 2024 Financial Results Announcement VerticalScope Holdings Inc. (TSX: FORA; OTCQX: VFORF) is gearing up to unveil its fourth quarter and full year financial results for 2024. This announcement is eagerly awaited by investors and community members alike, as it reflects the company's performance and growth in the digital enthusiast platform space....

Continue Reading